[Sickle cell disease: laboratory and hemoglobin study].
The diagnosis of any sickle cell disease syndrome is based on the unambiguous identification of HbS. Electrophoretic tests are usually the first to be performed. A much better resolution is obtained with isoelectricfocusing than with the more conventional cellulose acetate electrophoresis at alkaline pH. In some laboratories the first test is cation exchange HPLC. The diagnosis of HbS should never be accepted if not confirmed by a second test, more specific of this Hb such as the solubility test or electrophoresis on agar in citrate buffer. The laboratory should also evaluate other factors interacting with HbS, such as HbF level, sickle cell restriction haplotype, association with alpha-thalassemias. It should also evaluate other cellular factors and, in case of symptomatic heterozygous patients, help to understand of the underlying mechanisms.
Wajcman
H
H
INSERM U468 et Biochimie, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France. henri.wajcman@im3.inserm.fr
Galacteros
F
F
D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D002851:Chromatography, High Pressure Liquid; D004586:Electrophoresis / Q000379:methods; D004906:Erythrocyte Count; D006451:Hemoglobin, Sickle / Q000032:analysis*; D006579:Heterozygote; D006801:Humans; D006863:Hydrogen-Ion Concentration; D013789:Thalassemia / Q000150:complications / Q000175:diagnosis
D006451:Hemoglobin, Sickle